Free-breathing diffusion-weighted imaging for the assessment of inflammatory activity in crohn's disease

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 4, 2009, Pages 880-886

  Kiryu, Shigeru ^a,b   Dodanuki, Keiichi ^b   Takao, Hidemasa ^c   Watanabe, Makoto ^a   Inoue, Yusuke ^a   Takazoe, Masakazu ^b   Sahara, Rikisaburo ^b   Unuma, Kiyohito ^b   Ohtomo, Kuni ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b Social Insurance Central General Hospital   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Crohn's disease; Diffusion weighted images; Inflammatory bowel disease; Intestines; Magnetic resonance imaging

Indexed keywords

BARIUM;

ADULT; AGED; ARTICLE; ASCENDING COLON; BREATHING; CLINICAL ARTICLE; CROHN DISEASE; DESCENDING COLON; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE ACTIVITY; FEMALE; HUMAN; ILEUM; JEJUNUM; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECTUM; SENSITIVITY AND SPECIFICITY; SIGMOID; TRANSVERSE COLON;

CROHN DISEASE; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; RESPIRATORY-GATED IMAGING TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 65249115888     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21725     Document Type: Article

References (37)

1. Gyde SN, Prior P, Macartney JC, Thompson H, Waterhouse JA, Allan RN. Malignancy in Crohn's disease. Gut 1980;21:1024-1029.
2. Kirk GR, Clements WD. Crohn's disease and colorectal malignancy. Int J Clin Pract 1999;53:314-315.
3. Bell S, Kamm MA. Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease. Lancet 2000;355:858-860.
4. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study ofchimeric monoclonal antibodycA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997;337:1029-1035.
5. Sandborn WJ, Loftus EV. Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease. Gut 2004;53: 780-782.
6. Rieber A, Wruk D, Potthast S, et al. Diagnostic imaging in Crohn's disease: comparison of magnetic resonance imaging and conventional imaging methods. Int J Colorectal Dis 2000;15:176-181.
7. Pullman WE, Sullivan PJ, Barratt PJ, Lising J, Booth JA, Doe WF. Assessment of inflammatory bowel disease activity by technetium 99m phagocyte scanning. Gastroenterology 1988;95:989-996.
8. Gore RM, Balthazar EJ, Ghahremani GG, Miller FH. CT features of ulcerative colitis and Crohn's disease. AJR Am J Roentgenol 1996; 167:3-15.
9. Meyers MA, McGuire PV. Spiral CT demonstration of hypervascu- larity in Crohn disease: "vascular jejunization of the ileum" or the "comb sign". Abdom Imaging 1995;20:327-332.
10. Fidler J. MR imaging of the small bowel. Radiol Clin North Am 2007;45:317-331.
11. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Papam- astorakis G, Prassopoulos P, Roussomoustakaki M. Assessment of Crohn's disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol 2004;14:1017- 1024.
12. Kettritz U, Isaacs K, Warshauer DM, Semelka RC. Crohn's disease. Pilot study comparing MRI of the abdomen with clinical evaluation. J Clin Gastroenterol 1995;21:249-253.
13. Koh DM, Miao Y, Chinn RJ, et al. MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol 2001;177:1325- 1332.
14. Low RN, Sebrechts CP, Politoske DA, et al. Crohn disease with endoscopic correlation: single-shot fast spin-echo and gadolinium- enhanced fat-suppressed spoiled gradient-echo MR imaging. Radiology 2002;222:652-660.
15. Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 2000; 25:219-228.
16. Sempere GA, Martinez Sanjuan V, Medina Chulia E, et al. MRI evaluation of inflammatory activity in Crohn's disease. AJR Am J Roentgenol 2005;184:1829-1835.
17. van Oostayen JA, Wasser MN, van Hogezand RA, Griffioen G, de Roos A. Activity of Crohn disease assessed by measurement of superior mesenteric artery flow with Doppler US. Radiology 1994; 193:551-554.
18. Bicik I, Bauerfeind P, Breitbach T, von Schulthess GK, Fried M. Inflammatory bowel disease activity measured by positron-emission tomography. Lancet 1997;350:262.
19. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006;21:1104-1108.
20. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007;242:647-649.
21. Moseley ME, Cohen Y, Mintorovitch J, et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med 1990;14: 330-346.
22. Ebisu T, Tanaka C, Umeda M, et al. Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging 1996;14:1113-1116.
23. Noguchi K, Watanabe N, Nagayoshi T, et al. Role of diffusion-weighted echo-planar MRI in distinguishing between brain abscess and tumour: a preliminary report. Neuroradiology 1999;41:171-174.
24. Chan JH, Tsui EY, Luk SH, et al. Diffusion-weighted MR imaging of the liver: distinguishing hepatic abscess from cystic or necrotic tumor. Abdom Imaging 2001;26:161-165.
25. Kiryu S, Watanabe M, Kabasawa H, Akahane M, Aoki S, Ohtomo K. Evaluation of super paramagnetic iron oxide-enhanced diffusion- weighted PROPELLER T2-fast spin echo magnetic resonance imaging: preliminary experience. J Comput Assist Tomogr 2006;30: 197-200.
26. Muller MF, Prasad P, Siewert B, Nissenbaum MA, Raptopoulos V, Edelman RR. Abdominal diffusion mapping with use of a whole- body echo-planar system. Radiology 1994;190:475-478
27. Muller MF, Prasad PV, Bimmler D, Kaiser A, Edelman RR. Functional imaging of the kidney by means of measurement of the apparent diffusion coefficient. Radiology 1994;193:711-715
28. Okada Y, Ohtomo K, Kiryu S, Sasaki Y. Breath-hold T2-weighted MRI of hepatic tumors: value ofecho planar imagingwith diffusion- sensitizing gradient. J Comput Assist Tomogr 1998;22:364-371
29. Taouli B, Chouli M, Martin AJ, Qayyum A, Coakley FV, Vilgrain V. Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 2008;28:89-95.
30. Taouli B, Martin AJ, Qayyum A, et al. Parallel imaging and diffusion tensor imaging for diffusion-weighted MRI of the liver: preliminary experience in healthy volunteers. AJR Am J Roentgenol 2004; 183:677-680.
31. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22:275-282.
32. Herlinger H. A modified technique for the double-contrast small bowel enema. Gastrointest Radiol 1978;3:201-207.
33. Maglinte DD, Chernish SM, Kelvin FM, O'Connor KW, Hage JP. Crohn disease of the small intestine: accuracy and relevance of enteroclysis. Radiology 1992;184:541-545.
34. Maglinte DD, Gourtsoyiannis N, Rex D, Howard TJ, Kelvin FM. Classification of small bowel Crohn's subtypes based on multimodality imaging. Radiol Clin North Am 2003;41:285-303.
35. Low RN, Gurney J. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging 2007;25:848- 858.
36. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusion- weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006;239:122-130.
37. Kwee TC, Takahara T, Koh DM, Nievelstein RA, Luijten PR. Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver. J Magn Reson Imaging 2008;28:1141-1148.